Management of Migraine during Menstruatio

Phase 3

• Conditions: Health Condition 1: G439- Migraine, unspecified

• Registration Number: CTRI/2023/03/050282
• Lead Sponsor: Dr Indrani Roy Choudhury

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 3 April 2023

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Menstruating females suffering from pulsating, throbbing pain, lasting for 4-72hrs.Associated with nausea , vomiting, photophobia, phonophobia and irritability. Movement aggravates the pain hence quiet ,dark room is preferrable.Intensity of pain may cause disruption of normal daily activities.

Exclusion Criteria

1. Females suffering from any kind of systemic disorders or comorbidities.

2. Pregnant and lactating mothers.

3. Females having gross neurological problems

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To know the effectiveness of homoeopathic similimum in management and treatment of migraine in menstruating femalesTimepoint: Follow up will be taken at every 30 days by assessing with MIDAS, Headache Impact Test, 24hr Quality of Life Questionare in subsequent menstrual cycles for total duration of 5 months

Secondary Outcome Measures

Name	Time	Method
To reduce the frequency and intensity of migraine attacksusing homoeopathic individualised medicine. <br/ ><br>To know variations of intensity and frequency of migraine attacks in relation to menstrual phases.Timepoint: Assessmant done using MIDAS , Headache Impact Test And 24hr quality of Life Questionare during subsequent menstrual cycle.